Asston Pharmaceuticals Limited (BOM:544445)
79.25
+3.62 (4.79%)
At close: Mar 5, 2026
Asston Pharmaceuticals Market Cap
Asston Pharmaceuticals has a market cap or net worth of 674.65 million as of March 5, 2026.
Market Cap
674.65M
Enterprise Value
712.77M
Revenue
244.84M
Ranking
n/a
PE Ratio
21.07
Stock Price
79.25
Market Cap Chart
Since July 16, 2025, Asston Pharmaceuticals's market cap has decreased from 1.06B to 674.65M, a decrease of -36.57%. That is a compound annual growth rate of -51.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 674.65M | -3.97% |
| Dec 31, 2025 | 702.57M | -33.95% |
| Jul 16, 2025 | 1.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Concord Drugs | 988.78M |
| Mercury Laboratories | 948.00M |
| Makers Laboratories | 837.56M |
| Source Natural Foods and Herbal Supplements | 794.96M |
| Accretion Pharmaceuticals | 756.44M |
| Amwill Health Care | 669.12M |
| Onyx Biotec | 612.87M |
| Godavari Drugs | 585.20M |